262 related articles for article (PubMed ID: 11737157)
1. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.
Potschka H; Löscher W
Epilepsia; 2001 Oct; 42(10):1231-40. PubMed ID: 11737157
[TBL] [Abstract][Full Text] [Related]
2. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
Potschka H; Fedrowitz M; Löscher W
Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
[TBL] [Abstract][Full Text] [Related]
4. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.
Potschka H; Fedrowitz M; Löscher W
Neurosci Lett; 2002 Jul; 327(3):173-6. PubMed ID: 12113905
[TBL] [Abstract][Full Text] [Related]
5. Region-specific overexpression of P-glycoprotein at the blood-brain barrier affects brain uptake of phenytoin in epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Voskuyl RA; Redeker S; Aronica E; Wadman WJ; Gorter JA
J Pharmacol Exp Ther; 2007 Jul; 322(1):141-7. PubMed ID: 17392402
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models.
Uchida Y; Ohtsuki S; Terasaki T
Drug Metab Dispos; 2014 Oct; 42(10):1719-26. PubMed ID: 25061162
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain.
Potschka H; Fedrowitz M; Löscher W
Neuroreport; 2001 Nov; 12(16):3557-60. PubMed ID: 11733711
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
Ma A; Wang C; Chen Y; Yuan W
Drug Des Devel Ther; 2013; 7():1447-54. PubMed ID: 24348021
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance-associated protein is involved in the regulation of extracellular levels of phenytoin in the brain.
Potschka H; Löscher W
Neuroreport; 2001 Aug; 12(11):2387-9. PubMed ID: 11496115
[TBL] [Abstract][Full Text] [Related]
10. In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein.
Zhang C; Kwan P; Zuo Z; Baum L
Life Sci; 2010 Jun; 86(23-24):899-905. PubMed ID: 20417647
[TBL] [Abstract][Full Text] [Related]
11. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
12. Interaction of drugs with P-glycoprotein in brain capillaries.
Jetté L; Murphy GF; Leclerc JM; Beliveau R
Biochem Pharmacol; 1995 Nov; 50(10):1701-9. PubMed ID: 7503774
[TBL] [Abstract][Full Text] [Related]
13. Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier.
Jomura R; Akanuma SI; Bauer B; Yoshida Y; Kubo Y; Hosoya KI
Pharm Res; 2021 Jan; 38(1):113-125. PubMed ID: 33527223
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis study of the neuropharmacokinetics of phenytoin in rat hippocampus and frontal cortex.
Walker MC; Alavijeh MS; Shorvon SD; Patsalos PN
Epilepsia; 1996 May; 37(5):421-7. PubMed ID: 8617169
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
16. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.
Seegers U; Potschka H; Löscher W
Epilepsia; 2002 Jul; 43(7):675-84. PubMed ID: 12102668
[TBL] [Abstract][Full Text] [Related]
17. MDR1 gene expression in brain of patients with medically intractable epilepsy.
Tishler DM; Weinberg KI; Hinton DR; Barbaro N; Annett GM; Raffel C
Epilepsia; 1995 Jan; 36(1):1-6. PubMed ID: 8001500
[TBL] [Abstract][Full Text] [Related]
18. Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats.
Ferreira A; Rodrigues M; Meirinho S; Fortuna A; Falcão A; Alves G
Drug Chem Toxicol; 2021 Sep; 44(5):458-469. PubMed ID: 31020859
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of phenytoin induces efflux transporter overexpression in rats.
Alvariza S; Fagiolino P; Vázquez M; Feria-Romero I; Orozco-Suárez S
Pharmacol Rep; 2014 Dec; 66(6):946-51. PubMed ID: 25443719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
